TNF and rheumatoid arthritis: ADACTA study displayed that tocilizumab is more effective in RA monotherapy than adalimumab (TNF antagonist) while AMBITION study revealed that tocilizumab may be considered as the first biological drug more effective than methotrexate (Hernández et al. 2013).